1-[4-(4,5-dihydro-1H-imidazol-2-yl)aminophenyl]-3-(substituted phenyl)-2-propene-1-one as antiparkinsonian agents. 1986

V K Srivastava, and S Singh, and G Palit, and K Shanker

UI MeSH Term Description Entries
D007093 Imidazoles Compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons. Chemically reduced ones include IMIDAZOLINES and IMIDAZOLIDINES. Distinguish from 1,2-diazole (PYRAZOLES).
D008297 Male Males
D009043 Motor Activity Body movements of a human or an animal as a behavioral phenomenon. Activities, Motor,Activity, Motor,Motor Activities
D010095 Oxotremorine A non-hydrolyzed muscarinic agonist used as a research tool. Oxytremorine
D012110 Reserpine An alkaloid found in the roots of Rauwolfia serpentina and R. vomitoria. Reserpine inhibits the uptake of norepinephrine into storage vesicles resulting in depletion of catecholamines and serotonin from central and peripheral axon terminals. It has been used as an antihypertensive and an antipsychotic as well as a research tool, but its adverse effects limit its clinical use. Raunervil,Raupasil,Rausedil,Rausedyl,Serpasil,Serpivite,V-Serp,V Serp
D002621 Chemistry A basic science concerned with the composition, structure, and properties of matter; and the reactions that occur between substances and the associated energy exchange.
D005260 Female Females
D000814 Aniline Compounds Compounds that include the aminobenzene structure. Phenylamine,Phenylamines,Anilines,Compounds, Aniline
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000978 Antiparkinson Agents Agents used in the treatment of Parkinson's disease. The most commonly used drugs act on the dopaminergic system in the striatum and basal ganglia or are centrally acting muscarinic antagonists. Antiparkinson Drugs,Antiparkinsonian Agents,Antiparkinsonians,Agents, Antiparkinson,Agents, Antiparkinsonian,Drugs, Antiparkinson

Related Publications

V K Srivastava, and S Singh, and G Palit, and K Shanker
December 2010, Acta crystallographica. Section E, Structure reports online,
V K Srivastava, and S Singh, and G Palit, and K Shanker
September 2009, Acta crystallographica. Section E, Structure reports online,
V K Srivastava, and S Singh, and G Palit, and K Shanker
February 2009, Acta crystallographica. Section E, Structure reports online,
V K Srivastava, and S Singh, and G Palit, and K Shanker
June 2010, Acta crystallographica. Section E, Structure reports online,
V K Srivastava, and S Singh, and G Palit, and K Shanker
March 2009, Acta crystallographica. Section E, Structure reports online,
V K Srivastava, and S Singh, and G Palit, and K Shanker
July 2011, Acta crystallographica. Section E, Structure reports online,
V K Srivastava, and S Singh, and G Palit, and K Shanker
October 2009, Acta crystallographica. Section E, Structure reports online,
V K Srivastava, and S Singh, and G Palit, and K Shanker
June 2012, Acta crystallographica. Section E, Structure reports online,
V K Srivastava, and S Singh, and G Palit, and K Shanker
January 2011, Acta crystallographica. Section E, Structure reports online,
V K Srivastava, and S Singh, and G Palit, and K Shanker
January 2010, Acta crystallographica. Section E, Structure reports online,
Copied contents to your clipboard!